Abstract
Because of widespread use of mammography, clinically silent benign lesions are now easily detected, leading to pathological assessment to exclude the presence of malignancy. Fine needle aspiration cytology, needle core biopsies and excision biopsies are the methods used to confirm benignity and allay patient anxiety. When a woman has had a diagnosis of benign breast disease, more often than not she wishes to know what is the likelihood of the benign lesion predisposing to cancer at a later stage. With some conditions, such as fat necrosis, duct ectasia or hyalinised fibroadenoma, the physician can reassure the patient confidently. However, some benign proliferative diseases confer an increased risk of subsequent malignancy, although in most cases the risk is very small. These conditions require careful explanation to the patient, not to alarm them, but to encourage compliance with follow-up. The advantage of assessing the possible risk of progressing to malignancy in benign disease is that regular clinical and radiological follow-up can detect malignancy at an early, potentially curable stage.
Preview
Unable to display preview. Download preview PDF.
References
Allen RE (1990) The Concise Oxford Dictionary of Current English. 8th edn. Clarendon Press, Oxford, p 1040
Arthur JE, Ellis IO, Flowers C, Roebuck E, Elston CW, Blarney RW (1990) The relationship of “high risk” mammographic patterns to histological risk factors for development of cancer in the human breast. Br J Radiol 63:845–849
Beral V and Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427
Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TJ (1993) Prognostic significance of benign proliferative disease. Cancer 71:3896–3907
Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB (2000) Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference pathologists of the Canadian National Breast Screening Study. Eur J Cancer Prev 9:15–24
Byrne C, Schairer C, Brinton LA et al. (2001) Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 12:103–110
Cole P, Elwood JM, Kaplan SD (1978) Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol 108:112–120
Dupont WD (1989) Converting relative risks to absolute risks: a graphical approach. Stat Med 8:641–651
Dupont WD, Page DL (1989) Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol 20:723–725
Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146–151
Dupont WD, Page DL, Pari FF et al. (1994) Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 331:10–15
Dupont WD, Page DL, Pari FF et al. (1999) Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer 85:1277–1283
Dupont WD, Plummer WD (1996) Understanding the relationship between relative and absolute risk. Cancer 77:2193–2199
Ernster VL (1981) The epidemiology of benign breast disease. Epidemiol Rev 3:184–202
Fitzgibbons PL, Henson DE, Hutter RV for the Cancer Committee of the College of American Pathologists (1998) Benign breast changes and the risk for subsequent breast cancer. An update of consensus statement. Arch Pathol Med 122:1053–1055
Fleming NT, Armstrong BK, Sheiner HJ (1982) The comparative epidemiology of benign breast lumps and breast cancer in Western Australia. Int I Cancer 30:147–152
Friedenreich CM, Bryant HE, Alexander F, Hugh J, Danyluk J, Page DL (2000) Risk factors for benign proliferative breast disease. Int J Epidemiol 29:637–644
Gail MH, Brinton LA, Byar DP et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886
Hutter RVP et al. (1986) Is “fibrocystic disease” of the breast precancerous? Arch Pathol Lab Med 110:171–173
Jacobs TW, Bryne C, Colditz G, Connolly JL, Schnitt SJ (1999) Radial scars in benign breast biopsy specimens and the risk of breast cancer. N Engl J Med 340:430–436
Jensen RA, Page DL, Dupont WD, Rogers LW (1989) Invasive breast cancer in women with sclerosing adenosis. Cancer 64:1977–1983
Lilienfeld AM, Lilienfeld DE (1980) Morbidity statistics. In: Foundations of epidemiology, 2nd edn. Oxford University Press, Oxford, pp 138–139
London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941–944
Love SM, Gelman RS, Silen W (1982) Fibrocystic “disease” of the breast — a nondisease? N Engl J Med 307:1010–1014
McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D and the cancer and steroid hormone study group (1992) Histologic types of benign breast disease and the risk for breast cancer. Cancer 69:1408–1414
Mendell L, Rosenbloom M, Naimark A (1977) Are breast patterns a risk index for breast cancer? A reappraisal. Am J Roentgenol 128:547
Moskowitz M, Gartside P, McLaughlin C (1980) Mammographic patterns as markers for high-risk benign breast disease and incident cancers. Radiology 134:293–295
Page DL (1986) Cancer risk assessment in benign breast biopsies. Hum Pathol 17:871–874
Page DL (1992) The clinical significance of mammary epithelial hyperplasia. The Breast 1:3–7
Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55:2698–2708
Page DL, Dupont WD (1990) Anatomic markers of human pre-malignancy and risk of breast cancer. Cancer 66:1326–1335
Page DL, Salhany KE, Jensen RA, Dupont WD (1996) Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 78:258–266
Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH (1978) Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61:1055–1063
Saftlas AF, Hoover RN, Brinton LA et al. (1991) Mammographic densities and risk of breast cancer. Cancer 67:2833–2838
Shaaban AM, Sloane JP, West CR et al. (2002) Histopathologic types of benign breast lesions and the risk of breast cancer. Case-control study. Am J Surg Pathol 26:421–430
Steel N, Guest C (2002) Communicating risk. In: Pencheon D, Guest C, Melzer D, Muir Gray JA, (eds) Oxford handbook of public health practice. Oxford Press, Oxford, pp 442–443
Sterns EE, Zee B (2000) Mammographic density changes in pe-rimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable? Cancer Res Treat 59:125–132
Wellings SR, Wolfe JN (1978) Correlative studies of the histological and radiographic appearances of the breast parenchyma. Radiology 129:299–306
Wolfe JN (1976a) Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 126:1130–1139
Wolfe JN (1976b) Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37:2486–2492
Wolfe JN (1976c) Breast parenchymal patterns and their changes with age. Radiology 121:545–552
Wolfe JN, Saftlas AF, Salane M (1987) Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. Am J Roentgenol 148:1087–1092
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chinyama, C.N. (2004). Risk Assessment in Benign Breast Disease. In: Benign Breast Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18527-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-18527-4_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62146-8
Online ISBN: 978-3-642-18527-4
eBook Packages: Springer Book Archive